What is Picamilon?
Picamilon (also known as N-nicotinoyl-GABA or pikamilon) is a synthetic nootropic compound created by combining GABA (gamma-aminobutyric acid) with niacin (vitamin B3/nicotinic acid). Originally developed in the Soviet Union in the 1960s, picamilon was designed to overcome GABA’s inability to cross the blood-brain barrier effectively. The compound was used in Russia as a prescription medication for various neurological and psychiatric conditions before gaining attention in Western supplement markets.
In 2015, the FDA determined that picamilon does not meet the definition of a dietary supplement under U.S. law, as it is not a vitamin, mineral, herb, or other botanical, nor is it a dietary substance for use to supplement the diet. Consequently, products containing picamilon cannot be legally marketed as dietary supplements in the United States, though it remains available in some other countries.
Health benefits & uses
Anxiety and stress reduction (Limited evidence): Some small studies and anecdotal reports suggest picamilon may help reduce anxiety symptoms, potentially due to its GABA component’s calming effects once it reaches the brain. However, high-quality clinical trials are lacking.
Cognitive enhancement (Limited evidence): Preliminary research indicates picamilon might improve certain aspects of cognitive function, including attention and mental clarity, possibly through improved cerebral blood flow. The evidence base remains insufficient for strong conclusions.
Sleep quality (Limited evidence): Some users report improved sleep patterns when using picamilon, theoretically related to GABA’s role in sleep regulation. Scientific validation of these effects is minimal.
Blood circulation (Limited evidence): Early studies suggested picamilon might enhance cerebral blood flow and potentially benefit cardiovascular health, but robust clinical data is sparse.
How it works
Picamilon’s mechanism relies on its unique molecular structure. When ingested, picamilon crosses the blood-brain barrier more effectively than GABA alone due to the attached niacin molecule, which acts as a carrier. Once in the brain, enzymes break down picamilon, releasing both GABA and niacin.
The released GABA may then interact with GABA receptors in the brain, potentially producing calming, anxiolytic effects. GABA is the brain’s primary inhibitory neurotransmitter, helping to reduce neural excitability. Meanwhile, the niacin component may contribute to improved blood flow and cellular energy metabolism through its role in NAD+ synthesis.
This dual-action approach theoretically combines the relaxing properties of GABA with the circulation-enhancing effects of niacin, though the actual extent of these effects in humans requires further research.
Dosage
Due to limited clinical research and regulatory issues, there are no established recommended daily allowances (RDA) or upper limits (UL) for picamilon. Anecdotal reports from users suggest typical doses range from 50-200mg daily, often divided into 2-3 smaller doses.
Some sources suggest starting with lower doses (20-50mg) to assess tolerance before gradually increasing. However, without proper clinical guidelines and given the FDA’s position on picamilon, any use should be discussed with a healthcare provider familiar with nootropic compounds.
The lack of standardization in manufacturing and the compound’s regulatory status make dosing recommendations particularly uncertain and potentially unsafe without professional supervision.
Food sources
Picamilon does not occur naturally in foods. It is an entirely synthetic compound created in laboratories by chemically bonding GABA with niacin. While both GABA and niacin can be found in various foods, the specific picamilon molecule is only produced through chemical synthesis.
Natural sources of GABA include fermented foods, sprouted grains, and certain teas, while niacin is found in meat, fish, nuts, and enriched grains. However, consuming these foods would not provide picamilon itself.
Safety & side effects
Limited safety data exists for picamilon due to minimal clinical testing. Reported side effects from anecdotal sources include headaches, dizziness, nausea, and skin flushing (likely from the niacin component). Some users report fatigue or drowsiness, particularly at higher doses.
The niacin component may cause the characteristic “niacin flush” – temporary redness, warmth, and tingling of the skin. More concerning is the potential for interactions with medications and the unknown long-term effects of regular use.
The lack of regulatory oversight means product quality, purity, and actual picamilon content can vary significantly between manufacturers, adding additional safety concerns.
Interactions
Picamilon may potentially interact with several types of medications and supplements. It could theoretically enhance the effects of sedatives, anti-anxiety medications, or sleep aids due to its GABA component, potentially causing excessive drowsiness or respiratory depression.
The niacin component might interact with blood pressure medications, diabetes drugs, or cholesterol-lowering medications. Combining picamilon with alcohol or other central nervous system depressants could be particularly risky.
Other nootropic supplements or GABA-ergic compounds might have additive effects, potentially increasing the risk of side effects.
Who should be cautious
Several groups should exercise particular caution or avoid picamilon entirely. Pregnant and breastfeeding women should avoid it due to unknown safety profiles. Individuals with liver disease should be cautious, as the liver metabolizes both GABA and niacin.
People with low blood pressure, bleeding disorders, or those taking anticoagulant medications should consult healthcare providers before use. Those with a history of substance abuse should be particularly careful with any compound affecting brain neurotransmitters.
Given the FDA’s determination that picamilon is not a legal dietary supplement ingredient in the U.S., anyone considering its use should carefully consider the legal and safety implications.
Frequently asked questions
Is picamilon legal in the United States?
No, the FDA has determined that picamilon cannot be legally sold as a dietary supplement in the United States as of 2015. Products containing picamilon may still be found online but are not legally compliant with U.S. regulations.
How is picamilon different from taking GABA and niacin separately?
Picamilon is specifically designed to cross the blood-brain barrier more effectively than GABA alone. Taking GABA and niacin separately would not produce the same compound or necessarily the same effects, as they wouldn’t be chemically bonded.
Can picamilon be habit-forming?
While there’s limited research on picamilon’s addiction potential, any compound affecting GABA receptors theoretically carries some risk of dependence with regular use. More research is needed to fully understand this risk.
How long does it take for picamilon to work?
Anecdotal reports suggest effects may be felt within 30 minutes to 2 hours after ingestion, but individual responses vary significantly. The duration of effects is also poorly documented in scientific literature.
Are there safer alternatives to picamilon?
Several legal alternatives exist, including L-theanine, magnesium, or properly regulated GABA supplements, though their mechanisms and effects differ from picamilon. Consulting with a healthcare provider can help identify appropriate alternatives for specific health goals.
Classification:
Typical dose: — · Studied up to: —
References
Authoritative profile & live regulatory status: Picamilon on SupplementIndex →